| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.39B | +28.5% |
| Cost of Revenue | $10.90B | +26.5% |
| Gross Profit | $1.49B | +44.5% |
| R&D Expense | $118.2M | +51.5% |
| SG&A Expense | $259.9M | -11.4% |
| Operating Income | $1.04B | +73.7% |
| Pre-tax Income | $983.2M | +84.7% |
| Income Tax | $150.7M | +44.6% |
| Net Income | $832.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $595.6M | +40.7% |
| Accounts Receivable | $2.64B | +27.5% |
| Inventory | $2.19B | +24.3% |
| Current Assets | $5.67B | +25.7% |
| Total Assets | $7.21B | +20.5% |
| Current Liabilities | $3.94B | +30.4% |
| Long-term Debt | $750.5M | -2.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $659.5M | +39.2% |
| Investing Cash Flow | -$203.7M | +4.1% |
| Financing Cash Flow | -$283.5M | -36.0% |
| +94.5% |
| EPS (Basic) | $7.22 | +99.4% |
| EPS (Diluted) | $7.16 | +98.3% |
| Total Liabilities |
| $5.00B |
| +22.1% |
| Stockholders' Equity | $2.22B | +16.9% |